+49 (0) 3834 3914-0
info@cheplapharm.com
Drug Safety
About CHEPLAPHARM
Our Responsibility
Business Development
Management
Products
Press & News
Investor Relations
Creditor Relations
Investors Domain
Ratings
ESG
IR Contact & Events
Careers
Current Vacancies
Living in Greifswald
Career Opportunities
FAQ
Contact
Drug Safety
language
search
menu
Search
Search
chevron_right
Select language
Deutsch
English
Startpage
chevron_right
Press & News
Startpage
About CHEPLAPHARM
Our Responsibility
Business Development
Management
Products
Press & News
Investor Relations
Creditor Relations
Investors Domain
Ratings
ESG
IR Contact & Events
Careers
Current Vacancies
Living in Greifswald
Career Opportunities
FAQ
Contact
Drug Safety
support_agent
Your contact persons
CHEPLAPHARM Arzneimittel GmbH
+49 3834 3914-0
info@cheplapharm.com
View:
format_list_bulleted
grid_view
01/15/2014
CHEPLAPHARM continues its rapid growth: 50% sales increase in 2013 compared to the previous year.
Archive
Press releases
Read more
chevron_right
09/01/2010
CHEPLAPHARM attains the rights for HEMINEVRIN®/DISTRANEURIN®
Archive
Read more
chevron_right
chevron_left
1
2
3
Back
Back to top
expand_less